My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 105

    1.

    Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis.

    Shankar S, Chen Q, Sarva K, Siddiqui I, Srivastava RK.

    J Mol Signal. 2007 Oct 4;2:10.PMID: 17916240 [PubMed - in process]Related articlesFree article

    2.

    Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis.

    Shankar S, Ganapathy S, Chen Q, Srivastava RK.

    Mol Cancer. 2008 Jan 29;7:16.PMID: 18226269 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.

    Shankar S, Chen Q, Siddiqui I, Sarva K, Srivastava RK.

    J Mol Signal. 2007 Aug 24;2:7.PMID: 17718901 [PubMed - in process]Related articlesFree article

    4.

    Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells.

    Shankar S, Siddiqui I, Srivastava RK.

    Mol Cell Biochem. 2007 Oct;304(1-2):273-85. Epub 2007 Jul 17.PMID: 17636462 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms.

    Shankar S, Chen Q, Ganapathy S, Singh KP, Srivastava RK.

    Mol Cancer Ther. 2008 Aug;7(8):2328-38.PMID: 18723480 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis.

    Shankar S, Ganapathy S, Srivastava RK.

    Clin Cancer Res. 2008 Nov 1;14(21):6855-66.PMID: 18980980 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.

    Wahl H, Tan L, Griffith K, Choi M, Liu JR.

    Gynecol Oncol. 2007 Apr;105(1):104-12. Epub 2006 Dec 15.PMID: 17174384 [PubMed - indexed for MEDLINE]Related articles

    9.

    BH3 mimetic obatoclax enhances TRAIL-mediated apoptosis in human pancreatic cancer cells.

    Huang S, Okumura K, Sinicrope FA.

    Clin Cancer Res. 2009 Jan 1;15(1):150-9.PMID: 19118042 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).

    Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S.

    Cell Cycle. 2007 Dec 1;6(23):2953-61.PMID: 18156803 [PubMed - indexed for MEDLINE]Related articles

    11.

    Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

    Shankar S, Davis R, Singh KP, Kurzrock R, Ross DD, Srivastava RK.

    Mol Cancer Ther. 2009 Jun;8(6):1596-605. Epub 2009 Jun 9.PMID: 19509267 [PubMed - indexed for MEDLINE]Related articles

    12.

    ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.

    Song JH, Kandasamy K, Kraft AS.

    J Biol Chem. 2008 Sep 5;283(36):25003-13. Epub 2008 Jul 3.PMID: 18599488 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.

    Vogler M, Walczak H, Stadel D, Haas TL, Genze F, Jovanovic M, Gschwend JE, Simmet T, Debatin KM, Fulda S.

    Cancer Res. 2008 Oct 1;68(19):7956-65.PMID: 18829553 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.

    Yoo J, Park SS, Lee YJ.

    J Cell Biochem. 2008 Aug 1;104(5):1636-46.PMID: 18404675 [PubMed - indexed for MEDLINE]Related articles

    17.

    Downmodulation of dimethyl transferase activity enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in prostate cancer cells.

    Festuccia C, Gravina GL, D'Alessandro AM, Millimaggi D, Di Rocco C, Dolo V, Ricevuto E, Vicentini C, Bologna M.

    Int J Oncol. 2008 Aug;33(2):381-8.PMID: 18636160 [PubMed - indexed for MEDLINE]Related articles

    18.

    Combination of isoliquiritigenin and tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in colon cancer HT29 cells.

    Yoshida T, Horinaka M, Takara M, Tsuchihashi M, Mukai N, Wakada M, Sakai T.

    Environ Health Prev Med. 2008 Sep;13(5):281-7. Epub 2008 Jul 31.PMID: 19568915 [PubMed - in process]Related articlesFree article

    19.
    20.

    Rosiglitazone promotes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP.

    Kim YH, Jung EM, Lee TJ, Kim SH, Choi YH, Park JW, Park JW, Choi KS, Kwon TK.

    Free Radic Biol Med. 2008 Mar 15;44(6):1055-68. Epub 2007 Dec 8.PMID: 18164688 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk